These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 661031)

  • 81. [Surgical treatment of renovascular hypertension associated with bilateral renal artery stenosis. 1. Clinical study (author's transl)].
    Osada Y
    Nihon Hinyokika Gakkai Zasshi; 1978 Jun; 69(6):754-61. PubMed ID: 703008
    [No Abstract]   [Full Text] [Related]  

  • 82. [Preeminence of intravenous urography in the detection of surgically curable renovascular hypertension].
    Fournier A; Girard J; Plainfossé MC; Safar M; Laval-Jeantet M; Weil B; Bernard J; Milliez P
    Ann Med Interne (Paris); 1971 Nov; 122(11):1103-12. PubMed ID: 4338416
    [No Abstract]   [Full Text] [Related]  

  • 83. Saralasin test as a diagnostic and prognostic aid in renovascular hypertensive patients subjected to renal operation.
    Poutasse EF; Gonzalez-Serva L; Wendelken JR; Franz JP
    Trans Am Assoc Genitourin Surg; 1979; 71():96-100. PubMed ID: 545821
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Renal autotransplantion in patients with reno-vascular hypertension. Late results (author's transl)].
    Martínez P; Martínez L; Valdés G
    Rev Med Chil; 1981 Feb; 109(2):113-9. PubMed ID: 7022600
    [No Abstract]   [Full Text] [Related]  

  • 85. Angiotensin blockade in coarctation of the aorta.
    Ribeiro AB; Krakoff LR
    N Engl J Med; 1976 Jul; 295(3):148-50. PubMed ID: 1272332
    [No Abstract]   [Full Text] [Related]  

  • 86. [The Kaplan-Silah test in the diagnosis of renovascular hypertension].
    Recenti Prog Med; 1966 Aug; 41(2):166-9. PubMed ID: 4292443
    [No Abstract]   [Full Text] [Related]  

  • 87. Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;
    Streeten DH; Anderson GH; Freiberg JM; Dalakos TG
    N Engl J Med; 1975 Mar; 292(13):657-62. PubMed ID: 235090
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Study of sar-ala8 angiotensin II (saralasin) responsiveness in hypertension of renal origin.
    Arendell R; Lawson JD; Petracek MR; Meacham PW; Hollifield JW; Dean RH
    J Surg Res; 1978 Apr; 24(4):284-7. PubMed ID: 642496
    [No Abstract]   [Full Text] [Related]  

  • 89. [Renovascular hypertension: pathophysiology and operative indications].
    Eigler FW
    Thoraxchir Vask Chir; 1972 Oct; 20(5):355-60. PubMed ID: 4344334
    [No Abstract]   [Full Text] [Related]  

  • 90. [Split renal function studies: Comparative study of various split renal function tests and renal vein renin ratio in diagnosing renovascular hypertension (author's transl)].
    Hidai H; Fujishima S
    Nihon Hinyokika Gakkai Zasshi; 1977 Oct; 68(10):952-9. PubMed ID: 592597
    [No Abstract]   [Full Text] [Related]  

  • 91. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Diagnostic value of plasma renin activity and plasma angiotensin II in renovascular hypertension.
    Fukuchi S; Nakajima K
    Jpn Circ J; 1975 Jul; 39(7):823-7. PubMed ID: 1159943
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Studies on hypertension: I) The effects of angiotensin II and norepinephrine infusion on renal hemodynamics and renin angiotensin system in anesthetized dogs. II) The metabolism of 3H-DOPA in two kidney Goldblatt dogs (author's transl)].
    Kita T
    Nihon Jinzo Gakkai Shi; 1978 Aug; 20(8):931-41. PubMed ID: 713169
    [No Abstract]   [Full Text] [Related]  

  • 94. [Differential diagnosis of hypertension using the angiotensin II antagonist saralasin].
    Knauf H; Burmeister P; Büttner C; Hoppe-Seyler G; Schollmeyer P
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():214-5. PubMed ID: 613578
    [No Abstract]   [Full Text] [Related]  

  • 95. [Surgical results and prognosis of renovascular hypertension in Japan (author's transl)].
    Hidai H; Horiuchi M; Wada T; Yoshida S; Onoue M
    Nihon Hinyokika Gakkai Zasshi; 1973 Dec; 64(12):1042-52. PubMed ID: 4800022
    [No Abstract]   [Full Text] [Related]  

  • 96. [Clinical evaluation of 1-sarcosine, 8-isoleusine angiotensin II test on renovascular hypertension (author's transl)].
    Yokoyama E; Kumamoto Y; Furuya S; Miyamoto S
    Nihon Hinyokika Gakkai Zasshi; 1978 Feb; 69(2):154-64. PubMed ID: 661031
    [No Abstract]   [Full Text] [Related]  

  • 97. [Anesthetic management of a renovascular hypertension with an angiotensin II analogue (author's transl)].
    Takeda K; Sumikawa K; Kitamura K
    Masui; 1978 Dec; 27(13):1627-31. PubMed ID: 366192
    [No Abstract]   [Full Text] [Related]  

  • 98. [Effect of [Sar1, ile8] angiotensin II and SW 14,225 in renovascular hypertension--comparison between unilateral and bilateral renal artery stenosis (author's transl)].
    Ohta H; Ishida Y; Hara H; Yamamoto Y; Maekawa M; Takata M; Shimao M; Arai S; Takabatake T; Hattori N; Nomura G
    Nihon Jinzo Gakkai Shi; 1982 Jan; 24(1):79-88. PubMed ID: 7047821
    [No Abstract]   [Full Text] [Related]  

  • 99. Predictive value of angiotensin II blockade with (sarcosine-1, threonine-8) angiotensin II in renovascular hypertension.
    Novick AC; Fouad FM; Textor SC; Bravo EL; Tarazi RC; Gifford RW; Vidt DG
    J Urol; 1983 Jan; 129(1):7-10. PubMed ID: 6827687
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Significance of the saralasin infusion test in the diagnosis of arterial hypertension].
    Glorioso N; Madeddu P; Dessì-Fulgheri P; Meloni F; Palermo M; Fiori C; Rappelli A
    Boll Soc Ital Cardiol; 1980; 25(9):1035-46. PubMed ID: 7025868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.